These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 17003913

  • 1. The pharmacology of selective inhibition of COX-2.
    Grosser T.
    Thromb Haemost; 2006 Oct; 96(4):393-400. PubMed ID: 17003913
    [Abstract] [Full Text] [Related]

  • 2. Cardiovascular complications of non-steroidal anti-inflammatory drugs.
    Fosslien E.
    Ann Clin Lab Sci; 2005 Oct; 35(4):347-85. PubMed ID: 16254252
    [Abstract] [Full Text] [Related]

  • 3. [Innovation of anti-inflammatory drugs--inhibition of cyclooxygenases].
    Guo ZR.
    Yao Xue Xue Bao; 2005 Nov; 40(11):967-9. PubMed ID: 16499077
    [No Abstract] [Full Text] [Related]

  • 4. Stronger inhibition by nonsteroid anti-inflammatory drugs of cyclooxygenase-1 in endothelial cells than platelets offers an explanation for increased risk of thrombotic events.
    Mitchell JA, Lucas R, Vojnovic I, Hasan K, Pepper JR, Warner TD.
    FASEB J; 2006 Dec; 20(14):2468-75. PubMed ID: 17142796
    [Abstract] [Full Text] [Related]

  • 5. Pharmacodynamic of cyclooxygenase inhibitors in humans.
    Capone ML, Tacconelli S, Di Francesco L, Sacchetti A, Sciulli MG, Patrignani P.
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):85-94. PubMed ID: 17164136
    [Abstract] [Full Text] [Related]

  • 6. Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk.
    Hermann M, Ruschitzka F.
    Intern Med J; 2006 May; 36(5):308-19. PubMed ID: 16650196
    [Abstract] [Full Text] [Related]

  • 7. COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs.
    Mitchell JA, Warner TD.
    Nat Rev Drug Discov; 2006 Jan; 5(1):75-86. PubMed ID: 16485347
    [Abstract] [Full Text] [Related]

  • 8. COX-2 inhibitors and cardiovascular risk.
    Funk CD, FitzGerald GA.
    J Cardiovasc Pharmacol; 2007 Nov; 50(5):470-9. PubMed ID: 18030055
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular risks of cyclooxygenase inhibition.
    Stacy ZA, Dobesh PP, Trujillo TC.
    Pharmacotherapy; 2006 Jul; 26(7):919-38. PubMed ID: 16803424
    [Abstract] [Full Text] [Related]

  • 10. Does a coxib-associated thrombotic risk limit the clinical use of the compounds as analgesic, antiinflammatory drugs? Arguments against.
    Weber AA, Hohlfeld T, Harder S.
    Thromb Haemost; 2006 Oct; 96(4):413-6. PubMed ID: 17003916
    [Abstract] [Full Text] [Related]

  • 11. Cardiovascular hazard and non-steroidal anti-inflammatory drugs.
    Wang D, Wang M, Cheng Y, Fitzgerald GA.
    Curr Opin Pharmacol; 2005 Apr; 5(2):204-10. PubMed ID: 15780832
    [Abstract] [Full Text] [Related]

  • 12. [Cardiovascular and gastrointestinal risks associated with selective and non-selective NSAIDs].
    van den Bemt BJ, Benraad HB, Rasker JJ.
    Ned Tijdschr Geneeskd; 2007 May 12; 151(19):1062-7. PubMed ID: 17552414
    [Abstract] [Full Text] [Related]

  • 13. Gastrointestinal safety of novel nonsteroidal antiinflammatory drugs: selective COX-2 inhibitors and beyond.
    Coruzzi G, Venturi N, Spaggiari S.
    Acta Biomed; 2007 Aug 12; 78(2):96-110. PubMed ID: 17933277
    [Abstract] [Full Text] [Related]

  • 14. Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing process.
    Vuolteenaho K, Moilanen T, Moilanen E.
    Basic Clin Pharmacol Toxicol; 2008 Jan 12; 102(1):10-4. PubMed ID: 17973900
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of both COX-1 and COX-2 and resulting decrease in the level of prostaglandins E2 is responsible for non-steroidal anti-inflammatory drug (NSAID)-dependent exacerbation of colitis.
    Tanaka K, Suemasu S, Ishihara T, Tasaka Y, Arai Y, Mizushima T.
    Eur J Pharmacol; 2009 Jan 28; 603(1-3):120-32. PubMed ID: 19101538
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Eicosanoids and the vascular endothelium.
    Egan K, FitzGerald GA.
    Handb Exp Pharmacol; 2006 Jan 28; (176 Pt 1):189-211. PubMed ID: 16999220
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.